Westmead Millennium Institute logo

 

 

Professor Jeremy Chapman Professor Jeremy Chapman

Director AIM Network

Professor Jeremy Chapman is Director of AIM Network. He is also Director of Renal Medicine, Westmead Hospital, Chair of the Australian Bone Marrow Donor Registry, President Elect of The International Transplantation Society, Immediate-Past President of the World Marrow Donor Association and past Chair of the Westmead Research Hub Executive and Scientific Advisory Committee.

 

In his role as Director of Renal Services at Westmead Hospital, he has been involved in the development of the renal transplant program and the Australian National Pancreas Transplant program. This service has had continuous peer reviewed funding for research in transplantation, xenotransplantation, islet transplantation and progression of renal disease for the past 20 years.

 

He has guided the NSW Tissue Typing Laboratory at the Red Cross, developed the Centre for Organ and Tissue Donation, now entitled Life Link, at the Australian Red Cross Blood Service and has chaired the creation of the Australian Bone Marrow Donor Registry and development of the Cord Blood Bank Network of Australia.

 

 

Research Interests

Research Interests include:

  • histocompatibility
  • unrelated bone marrow transplantation
  • clinical islet transplantation
  • islet xenotransplantation
  • clinical immunosuppression.
  • cancer after renal transplantation.

 

Back to the top

 

Publications

2006

  • Vajdic, C, McDonald, S, McCredie, M, van Leeuwen, M, Stewart, J, Law, M, Chapman, JR, Webster, A, Kaldor, J, Grulich, A. Cancer incidence before and after kidney transplantation. JAMA : the journal of the American Medical Association. 2006; 296:2823-31 [Abstract]
  • Chapman, JR. Scoring arteriolar hyalinosis in renal allograft biopsies: so important and yet so tricky. Nature clinical practice. Nephrology. 2006; 2:622-3 [Abstract]
  • Mathew, T, Chapman, JR. Organ donation: a chance for Australia to do better. Medical Journal of Australia. 2006; 185:245-246 [Abstract]
  • Nankivell, B, Chapman, JR. The Significance of Subclinical Rejection and the Value of Protocol Biopsies. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2006; 6:2006-12 [Abstract]
  • Chapman, JR, Bock, A, Dussol, B, Fritsche, L, Kliem, V, Lebranchu, Y, Oppenheimer, F, Pohanka, E, Salvadori, M, Tufveson, G. Follow-up after renal transplantation with organs from donors after cardiac death. Transplant international : official journal of the European Society for Organ Transplantation. 2006; 19:715-9 [Abstract]
  • Chapman, JR, Nankivell, B. Nephrotoxicity of ciclosporin A - short-term gain, long-term pain?. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2006; 21:2060-3 [Abstract]
  • Kee, T, Chapman, JR, O'Connell, P, Fung, C, Allen, R, Kable, K, Vitalone, M, Nankivell, B. Treatment of Subclinical Rejection Diagnosed by Protocol Biopsy of Kidney Transplants. Transplantation. 2006; 82:36-42 [Abstract]
  • Chapman, JR. Guest editor's introduction. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2006; 21 Suppl 3:iii1-iii2
  • Chapman, JR. Managing cardiovascular risk in renal transplant recipients: The ruole of everolimus - Guest editor's introduction. Nephrology Dialysis Transplantation. 2006; 21:iii1-iii2
  • Allen, R, Lau, H, Nankivell, B, O'Connell, P, Lennox, A, Pussell, B, Chapman, JR. When all the planets are in alignment. Immunology and Cell Biology. 2006; 84:A22-A22
  • Wavamunno, M, Vitalone, M, Borrows, R, Fung, C, Allen, R, O'Connell, P, Chapman, JR, Nankivell, B. Mycophenolate mofetil reduces the histological expression of chronic allograft nephropathy. Immunology and Cell Biology. 2006; 84:A11-A11
  • Chadban, S, Campbell, S, Russ, G, Walker, R, Chapman, JR, Pussell, B, Trevillian, P, Ierino, F, Thompson, N, Hutchison, B, Irish, A. A one-year, randomised, open label, parallel group study to investigate the safety and efficacy of enteric-coated Mycophenolate sodium (EC-MPS) in combination with full dose or reduced dose cyclosporine microemulsion (CSA-ME), basiliximab and steroids in de novo kidney transplantation. Immunology and Cell Biology. 2006; 84:A6-A6
  • Goddard, K, Pleass, H, Cross, N, O'Connell, P, Chapman, JR, Nankivell, B, Allen, R. A twist of fate or fated to twist?. Immunology and Cell Biology. 2006; 84:A6-A6
  • Robertson, P, Allen, R, O'Connell, P, Pleass, H, Nankivell, B, Waugh, D, Chapman, JR. Transplant beta cell function and the 'lazarus factor'. Immunology and Cell Biology. 2006; 84:A10-A10
  • Vitalone, M, Kirk, M, Allen, R, Pleass, H, Chapman, JR, O'Connell, P, Nankivell, B. Epithelial-to-mesenchymal transition (EMT) in chronic allograft nephropathy (CAN). Immunology and Cell Biology. 2006; 84:A2-A2
  • Webster, A, Craig, J, Chapman, JR. Rate and relative risk of common cancers in kidney transplant recipients in Australia and New Zealand. Immunology and Cell Biology. 2006; 84:A13-A13
  • Chapman, JR. Long-term safety and tolerability after conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS, myfortic) in stable maintenance renal transplant recipients. Immunology and Cell Biology. 2006; 84:A7-A7
  • Webster, A, Ruster, L, Playford, E, Higgins, G, Chapman, JR, Craig, J. IL2 receptor antagonists for renal transplant recipients: An updated meta-analysis of randomised trials. Immunology and Cell Biology. 2006; 84:A3-A3
  • Eris, J, Russ, G, Hutchison, B, Walker, R, Chapman, JR, Pussell, B, Mahoney, J, Campbell, S, Brault, Y, Burke, J, Scarola, J, Neylan, J. Sirolimus therapy after early cyclosporine withdrawal reduces the risk of malignancy at 5 years after renal transplantation. Immunology and Cell Biology. 2006; 84:A19-A19
  • Webster, A, Lee, V, Chapman, JR, Craig, J. Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation. 2006; 81:1234-48 [Abstract]
  • Salvadori, M, Rosati, A, Bertoni, E, Bock, A, Chapman, J, Dussol, B, Fritsche, L, Kliem, V, Lebranchu, Y, Oppenheimer, F, Pohanka, E, Tufveson, G, Soergel, M. Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: An insight from MOST, a multinational observational study. Transplantation Proceedings. 2006; 38:1010-1013
  • Webster, A, Pankhurst, T, Rinaldi, F, Chapman, JR, Craig, J. Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: a systematic review of randomized trial data. Transplantation. 2006; 81:953-65 [Abstract]
  • Chapman, JR. Not all donors are equal. Transplantation. 2006; 81:976-7 [Abstract]
  • Nankivell, B, Chapman, J. Chronic allograft nephropathy: current concepts and future directions. Transplantation. 2006; 81:643-54 [Abstract]
  • O'Connell, P, Hawthorne, W, Holmes-Walker, D, Nankivell, B, Gunton, J, Patel, A, Walters, S, Pleass, H, Allen, R, Chapman, JR. Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial. The Medical journal of Australia. 2006; 184:221-5 [Abstract]
  • Salvadori, M, Rosati, A, Bock, A, Chapman, JR, Dussol, B, Fritsche, L, Kliem, V, Lebranchu, Y, Oppenheimer, F, Pohanka, E, Tufveson, G, Bertoni, E. Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant. Transplantation. 2006; 81:202-206 [Abstract]
  • Webster, A, Lee, V, Chapman, JR, Craig, J. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients. Cochrane database of systematic reviews (Online : Update Software). 2006; 19:CD004290 [Abstract]
  • Webster, A, Pankhurst, T, Rinaldi, F, Chapman, JR, Craig, J. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients. Cochrane database of systematic reviews (Online : Update Software). 2006; 19:CD004756 [Abstract]

 

Back to the top

 

Contact details

T +61 2 9845 6349
F +61 2 9633 8300
E Jeremy_Chapman@wsahs.nsw.gov.au

 

Back to the top

 

 

 

 

 

 

 

 

 

 

| Home | About Us | Research | Our People | The Millennium Foundation | News & Events | Contact Us | Search |

 

© 2000-2007 Westmead Millennium Institute